ERGO.L - Ergomed plc

LSE - LSE Delayed price. Currency in GBp

Ergomed plc

The Surrey Research Park
1 Occam Court
Guildford GU2 7HJ
United Kingdom
44 1483 503 205
http://www.ergomedplc.com

SectorHealthcare
IndustryBiotechnology
Full-time employees850

Key executives

NameTitlePayExercisedYear born
Dr. Miroslav ReljanovicFounder & Exec. Chairman151.49kN/A1959
Mr. Richard T. BarfieldCFO & Exec. DirectorN/AN/A1958
Mr. Lewis CameronChief Operating OfficerN/AN/A1964
Ms. Sanja JuricGen. Counsel & Company Sec.N/AN/AN/A
Dr. Shazia RahmanHead of HR & ResourcingN/AN/AN/A
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Ergomed plc provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. The company offers clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, neurology, and CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

Corporate governance

Ergomed plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more